ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutrition and Metabolism

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1605201

Prebiotic potential and metabolic benefits of Acorus gramineus rhizome-derived polysaccharides in a high-fat diet-induced obesity model

Provisionally accepted
  • Korea Food Research Institute (KFRI), Seongnam-si, Republic of Korea

The final, formatted version of the article will be published soon.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health issue that causes severe liver abnormalities and metabolic dysregulation, incurring substantial costs to healthcare systems. Acorus gramineus, a traditional remedy, has been studied for its anti-inflammatory and neuroprotective effects. However, its potential role in the management of metabolic disorders via its polysaccharide components remains unclear. This study aimed to investigate the effects of the A. gramineus rhizome-derived polysaccharide (AGRP) on prebiotic potential and metabolic health in a high-fat diet-induced obesity mouse model. AGRP showed prebiotic efficacy by targeting representative intestinal microorganisms and demonstrated the ability to promote butyrate production. Importantly, mice fed a high-fat diet supplemented with AGRP showed significant improvements in metabolic disease markers, including reductions in body fat and white adipose tissue mass, compared to those in controls. Additionally, serum metabolic analysis of AGRP-administered mice demonstrated positive changes in liver enzymes, lipid profile, and glucose metabolism, as well as reduced lipid accumulation and downregulation of lipogenic genes. AGRP increased the intestinal barrier function by modulating endotoxins and tight junction protein expression, demonstrating its interaction with improved intestinal health. These findings suggest that AGRP is a promising prebiotic with potential applications in the management of MASLD and related metabolic disorders.

Keywords: Acorus gramineus, Polysaccharides, Metabolic dysfunction-associated steatotic liver disease, metabloic endotoxemia, prebiotic

Received: 03 Apr 2025; Accepted: 27 May 2025.

Copyright: © 2025 Park, Chae, Lee, Lee, Lee, Hur and Park. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ho-Young Park, Korea Food Research Institute (KFRI), Seongnam-si, Republic of Korea

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.